Jonas Jegerborn

All filings by Jonas Jegerborn on record concern Generic Sweden AB (publ). We count 16 filings; the first trade dates from 10 April 2018 and the latest from 13 February 2025.

In open-market terms, that means 6 purchases worth €725k on one side and 10 sales worth €3.6M on the other. The net balance comes to €2.9M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2025: no purchases and 7 sales on the market.

Half of the purchases are above €164k and half below. 1 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Ninety days after publication, 6 purchases show a median change of -10.7%, with the price up in 17% of them. They describe history only and say nothing certain about the share price ahead.

Most recently, on 17 February 2025, the filings show an open-market sale worth €868k in Generic Sweden AB (publ). The last purchase on record was published on 26 November 2020, which is 2,173 days ago. Filings reach the Finansinspektionen feed a median of 4 days after the trade. The regulation allows three business days to notify a trade (MAR article 19). Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.